Olaparib (O) + ceralasertib (C) in patients (pts) with metastatic triple-negative breast cancer (mTNBC): Translational analysis of the VIOLETTE trial
Lukashchuk, Natalia, Punie, Kevin, Nowecki, Zbigniew, Im, Seock-Ah, Armstrong, Anne C., Jacot, William, Kim, Jee Hyun, Webster, Marc A., Balmaña, Judith, Delaloge, Suzette, Casson, Ed, Loembe, Bienvenu, Dean, Emma, Armenia, Joshua, Tutt, Andrew NJ
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain
Daniels, Stephen, Casson, Ed, Stegmann, Jens-Ulrich, Oh, Charles, Okamoto, Akiko, Rauschkolb, Christine, Upmalis, David
Published in Current medical research and opinion (01.06.2009)
Published in Current medical research and opinion (01.06.2009)
Get more information
Journal Article
A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK
Dean, Emma, Banerji, Udai, Schellens, Jan H. M., Krebs, Matthew G., Jimenez, Begona, van Brummelen, Emilie, Bailey, Chris, Casson, Ed, Cripps, Diana, Cullberg, Marie, Evans, Stephen, Foxley, Andrew, Lindemann, Justin, Rugman, Paul, Taylor, Nigel, Turner, Guy, Yates, James, Lawrence, Peter
Published in Cancer chemotherapy and pharmacology (01.05.2018)
Published in Cancer chemotherapy and pharmacology (01.05.2018)
Get full text
Journal Article
Results of OAK: A phase 1, open-label, multicentre study to compare two dosage forms of AZD5363 and to explore the effect of food on the pharmacokinetic (PK) exposure, safety, and tolerability of AZD5363 in patients with advanced solid malignancies
Dean, Emma Jane, Banerji, Udai, Schellens, Jan H. M., Krebs, Matthew, Jimenez, Begona, van der Noll, Ruud, Foxley, Andrew, Yates, James W T, Taylor, Nigel, Evans, Steve, Guy, Turner, Casson, Ed, Rugman, Paul, Salim, Shaista, Lindemann, Justin P O, Lawrence, Peter
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A pharmacokinetically (PK) and pharmacodynamically (PD) driven phase I trial of the pan-AKT inhibitor AZD5363 with expansion cohorts in PIK3CA mutant breast and gynecological cancers
Banerji, Udai, Dean, Emma Jane, Perez-Fidalgo, Jose Alejandro, Batist, Gerald, Bedard, Philippe L., You, Benoit, Westin, Shannon Neville, Kabos, Peter, Davies, Barry, Elvin, Paul, Lawrence, Peter, Yates, James W T, Ambrose, Helen, Rugman, Paul, Foxley, Andrew, Salim, Shaista, Casson, Ed, Lindemann, Justin P O, Schellens, Jan H. M.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article